HQH

abrdn Healthcare Investors

HQH

Market cap $898M

Overview Fund Activity

16.68 USD

-0.15

0.89%

At close Updated Sep 12, 4:00 PM EDT

Pre-market

After hours

16.67

-0.01

0.06%

1 day

-0.89%

5 days

-1.77%

1 month

4.91%

3 months

5.1%

6 months

0.36%

Year to date

2.77%

1 year

-11.04%

5 years

-18.95%

10 years

-49.42%

About: abrdn Healthcare Investors Formerly Tekla Healthcare Investors is the United States based non-diversified closed-end management investment company. Its objective is to seek long-term capital appreciation by investing in securities of healthcare companies. In addition, the fund seeks to provide regular distribution of realized capital gains. The fund invests in the securities of public and private companies.

Financials Asset Management

0

Funds holding %

of 7,462 funds

–

Analysts bullish %

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

113% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 8

45% more repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 29

8% more funds holding

Funds holding: 104 [Q1] → 112 (+8) [Q2]

2.97% less ownership

Funds ownership: 24.35% [Q1] → 21.39% (-2.97%) [Q2]

7% less capital invested

Capital invested by funds: $191M [Q1] → $179M (-$12.8M) [Q2]

See Fund Rankings

Financial journalist opinion

HQH: Income Approach To Play Healthcare Recovery

Berkshire Hathaway's purchase of UnitedHealth signals a potential bottom and renewed interest in the struggling healthcare sector. abrdn Healthcare Investors offers a 12.4% yield and trades at a -9.36% NAV discount, making it an attractive entry point. Key holdings in HQH have shown earnings recovery, and sector rotation may favor undervalued healthcare stocks as S&P 500 valuations remain high.

HQH: Income Approach To Play Healthcare Recovery

Bank On Healthcare And An Aging Population With 14% Yield: HQH

Healthcare spending continues to rise as Americans, on average, are getting older. We utilize funds to generate strong income from a growth-focused sector. Your retirement portfolio can readily pay your way!

Bank On Healthcare And An Aging Population With 14% Yield: HQH

ABERDEEN INVESTMENTS U.S. CLOSED-END FUNDS ANNOUNCE DISTRIBUTION PAYMENT DETAILS

PHILADELPHIA , Aug. 11, 2025 /PRNewswire/ -- The following Aberdeen Investments U.S. Closed-End Funds (NYSE: ACP, AGD, AOD, ASGI, AWP, HQH, HQL, IFN, THQ, THW and NYSE American: FAX, FCO, IAF, VFL), announced today that the closed end funds in the chart directly below will pay the distributions indicated on a per share basis on August 29, 2025 to all shareholders of record as of August 22, 2025 (ex-dividend date August 22, 2025). These dates apply to the Funds listed below with the exception of the abrdn Healthcare Investors (HQH), the abrdn Life Sciences Investors (HQL), the abrdn Australia Equity Fund, Inc. (IAF) and the India Fund, Inc. (IFN) which will pay on September 30, 2025, to all shareholders of record as of August 22, 2025 (ex-dividend date August 22, 2025).

ABERDEEN INVESTMENTS U.S. CLOSED-END FUNDS ANNOUNCE DISTRIBUTION PAYMENT DETAILS

High Risk, Low Return: The Problem With HQH's Biotech Tilt

HQH offers high yields with a biotech and small/mid-cap tilt, but relies on capital payouts, making it less tax-efficient and more volatile. Active management and venture capital-style investing add agility but increase risk, with portfolio holdings changing frequently and a heavy biotech concentration. Total returns have been uninspiring, with NAV erosion, funding payouts, and sector underperformance, especially compared to broader healthcare funds like BME.

High Risk, Low Return: The Problem With HQH's Biotech Tilt

2 Healthcare Picks For Distributions And Attractive Valuations

Healthcare CEFs are under pressure from regulatory shifts, but sector defensiveness and discounted valuations can create long-term opportunities. Within the CEF structure, we also have the added benefit that comes with the discount/premium dynamic inherent in the structure. We are looking at two names today that present investors with attractive distributions and that are looking like decently discounted opportunities.

2 Healthcare Picks For Distributions And Attractive Valuations

ABERDEEN INVESTMENTS U.S. CLOSED-END FUNDS ANNOUNCE DISTRIBUTION PAYMENT DETAILS

PHILADELPHIA , June 30, 2025 /PRNewswire/ -- The Aberdeen Investments U.S. Closed-End Funds (NYSE: ASGI, HQH, HQL, IFN, THQ), (NYSE American: IAF) (the "Funds" or individually the "Fund"), today announced that the Funds paid the distributions noted in the table below on June 30, 2025, on a per share basis to all shareholders of record as of June 23, 2025 (ex-dividend date June 23, 2025). These dates apply to the Funds listed below with the exception of abrdn Healthcare Investors (HQH), abrdn Life Sciences Investors (HQL), abrdn Australia Equity Fund, Inc. (IAF) and the India Fund Inc. (IFN) which paid on June 30, 2025, to all shareholders of record as of May 22, 2025 (ex-dividend date May 22, 2025).

ABERDEEN INVESTMENTS U.S. CLOSED-END FUNDS ANNOUNCE DISTRIBUTION PAYMENT DETAILS

CEF Insights: The Future Of Healthcare Investing

Groundbreaking AI-powered initiatives are set to transform the healthcare landscape, potentially revolutionizing cancer research and healthcare investing. Aberdeen Investments' four healthcare-focused closed-end funds meet various investor needs: THQ/THW for income and stability, HQH/HQL for growth and innovation exposure. Jason Akus, Portfolio Manager and Head of Healthcare Investments with Aberdeen Investments, gives insight into how new innovations may impact investment opportunities.

CEF Insights: The Future Of Healthcare Investing

HQH: Efficient Fund To Collect Income From Healthcare

I maintain my buy rating on HQH for its high 13.6% yield, strong dividend coverage, and efficient healthcare sector diversification. HQH trades at an 8% discount to NAV, offering an attractive entry point compared to peers, despite recent price declines. The fund is well-positioned to benefit from long-term healthcare sector growth, driven by rising spending and health-conscious trends.

HQH: Efficient Fund To Collect Income From Healthcare

HQH: A Good Balance Of Returns And Risks In The Healthcare Sector

HQH offers a compelling mix of high yield and growth exposure to healthcare, trading at a discount to NAV with recent outperformance versus benchmarks. The fund benefits from strong healthcare industry tailwinds—aging populations and innovation—while active management and share buybacks support narrowing the NAV discount. A robust 13.6% market yield and a fair value estimate 36% above current price highlight significant upside, though distribution sustainability must be monitored.

HQH: A Good Balance Of Returns And Risks In The Healthcare Sector

2 Fat Dividends For A Lifetime Of Passive Income

Berkshire Hathaway's portfolio of cash flow generators allows financial independence and opportunistic moves without financing dependencies. The "Income Method" aims to replicate Mr. Buffett's financial independence by prioritizing the generation of income streams from our personal portfolios. We discuss our top picks with yields of up to 15%.

2 Fat Dividends For A Lifetime Of Passive Income

See News Rankings

Charts implemented using Lightweight Charts™